85 related articles for article (PubMed ID: 25262704)
1. Dilution effect of serum CA125 and CA19-9 over a cutoff value, according to obesity.
Kim JH; Park BR; Yang WJ
Int J Biol Markers; 2015 Feb; 30(1):e122-6. PubMed ID: 25262704
[TBL] [Abstract][Full Text] [Related]
2. Effect of obesity-related plasma hemodilution on serum tumor marker concentration in women.
Park M; Chang IH; Kang H; Han SS
J Obstet Gynaecol Res; 2015 May; 41(5):784-9. PubMed ID: 25421332
[TBL] [Abstract][Full Text] [Related]
3. The diagnostic value of determination of serum GOLPH3 associated with CA125, CA19.9 in patients with ovarian cancer.
Fan HY; Duan DM; Liu YF
Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4039-4044. PubMed ID: 29028099
[TBL] [Abstract][Full Text] [Related]
4. The prognostic values of CA125, CA19.9, NSE, AND SCC for stage I NSCLC are limited.
Ma S; Shen L; Qian N; Chen K
Cancer Biomark; 2011-2012; 10(3-4):155-62. PubMed ID: 22674301
[TBL] [Abstract][Full Text] [Related]
5. CA125 is superior to CA19-9 in predicting the resectability of pancreatic cancer.
Luo G; Xiao Z; Long J; Liu Z; Liu L; Liu C; Xu J; Ni Q; Yu X
J Gastrointest Surg; 2013 Dec; 17(12):2092-8. PubMed ID: 24146342
[TBL] [Abstract][Full Text] [Related]
6. Comparison of risk of malignancy index (RMI), CA125, CA 19-9, ultrasound score, and menopausal status in borderline ovarian tumor.
Alanbay I; Akturk E; Coksuer H; Ercan M; Karaşahin E; Dede M; Yenen MC; Ozan H; Baser I
Gynecol Endocrinol; 2012 Jun; 28(6):478-82. PubMed ID: 22122561
[TBL] [Abstract][Full Text] [Related]
7. CA72-4 combined with CEA, CA125 and CAl9-9 improves the sensitivity for the early diagnosis of gastric cancer.
Yang AP; Liu J; Lei HY; Zhang QW; Zhao L; Yang GH
Clin Chim Acta; 2014 Nov; 437():183-6. PubMed ID: 25086284
[TBL] [Abstract][Full Text] [Related]
8. [Clinical value of serum CA19-9, CA125 and CP2 in mucinous ovarian tumor: a retrospective study of 273 patients].
Dong L; Cui H; Li XP; Sun LF; Chang XH; Liang XD; Zhu HL
Zhonghua Fu Chan Ke Za Zhi; 2008 Jan; 43(1):5-8. PubMed ID: 18366923
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical analysis of CA125, CA19-9, and Ki-67 in stage III or IV endometriosis: positive correlation between serum CA125 level and endometriotic epithelial cell proliferation.
Toki T; Kubota J; Lu X; Nakayama K
Acta Obstet Gynecol Scand; 2000 Sep; 79(9):771-6. PubMed ID: 10993101
[TBL] [Abstract][Full Text] [Related]
10. Retrospective evaluation of tumor markers in ovarian mature cystic teratoma and ovarian endometrioma.
Kataoka T; Watanabe Y; Hoshiai H
J Obstet Gynaecol Res; 2012 Aug; 38(8):1071-6. PubMed ID: 22568880
[TBL] [Abstract][Full Text] [Related]
11. Esophageal cyst producing CA19-9 and CA125.
Goto T; Maeshima A; Oyamada Y; Kato R
Interact Cardiovasc Thorac Surg; 2010 Mar; 10(3):448-50. PubMed ID: 20008896
[TBL] [Abstract][Full Text] [Related]
12. Clinical values of CA19-9, CA125 and CEA in malignant obstructive jaundice.
Ng WW; Tong KJ; Tam TN; Lee SD
Zhonghua Yi Xue Za Zhi (Taipei); 1995 Jun; 55(6):438-46. PubMed ID: 7634181
[TBL] [Abstract][Full Text] [Related]
13. The Diagnostic Accuracy of Combined Enolase/Cr, CA125, and CA19-9 in the Detection of Endometriosis.
Rokhgireh S; Mehdizadeh Kashi A; Chaichian S; Delbandi AA; Allahqoli L; Ahmadi-Pishkuhi M; Khodaverdi S; Alkatout I
Biomed Res Int; 2020; 2020():5208279. PubMed ID: 33062681
[TBL] [Abstract][Full Text] [Related]
14. Application value of Doppler ultrasound combined with CA125 and CA19.9 in the early diagnosis of epithelial ovarian cancer.
Cui Y; Shi S; Zhang S; Huang C; Li P; Han C
J BUON; 2021; 26(5):1802-1808. PubMed ID: 34761586
[TBL] [Abstract][Full Text] [Related]
15. Potential markers that complement expression of CA125 in epithelial ovarian cancer.
Rosen DG; Wang L; Atkinson JN; Yu Y; Lu KH; Diamandis EP; Hellstrom I; Mok SC; Liu J; Bast RC
Gynecol Oncol; 2005 Nov; 99(2):267-77. PubMed ID: 16061277
[TBL] [Abstract][Full Text] [Related]
16. [A resected case of intralobar pulmonary sequestration with increased serum tumor markers, CA19-9, CA125 and NCC-ST-439].
Nakamura H; Katsumi T; Nagata S; Saito M; Konaka C; Kato H
Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Dec; 35(12):1425-29. PubMed ID: 9567093
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of Preoperative Serum Levels of Five Tumor Markers (Carcinoembryonic Antigen, CA19-9, Alpha-fetoprotein, CA72-4, and CA125) in Gastric Cancer.
Kim JH; Jun KH; Jung H; Park IS; Chin HM
Hepatogastroenterology; 2014 May; 61(131):863-9. PubMed ID: 26176088
[TBL] [Abstract][Full Text] [Related]
18. Reference intervals for carcinoembryonic antigen (CEA), CA125, MUC1, Alfa-foeto-protein (AFP), neuron-specific enolase (NSE) and CA19.9 from the NORIP study.
Bjerner J; Høgetveit A; Wold Akselberg K; Vangsnes K; Paus E; Bjøro T; Børmer OP; Nustad K
Scand J Clin Lab Invest; 2008; 68(8):703-13. PubMed ID: 18609108
[TBL] [Abstract][Full Text] [Related]
19. Increased lung cancer risk in patients with interstitial lung disease and elevated CEA and CA125 serum tumour markers.
Dai H; Liu J; Liang L; Ban C; Jiang J; Liu Y; Ye Q; Wang C
Respirology; 2014 Jul; 19(5):707-13. PubMed ID: 24903079
[TBL] [Abstract][Full Text] [Related]
20. Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy.
Sun Z; Zhang N
World J Surg Oncol; 2014 Dec; 12():397. PubMed ID: 25543664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
